Shares of BioLife Solutions, Inc. (BLFS) have gained 1.6% over the past four weeks to close the last trading session at $22.37, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$31.3 indicates a potential upside of 39.9%.The average comprises 10 short-term price targets ranging from a low of $30.00 to a high of$34.00, with a standard deviation of $1.42. While the lowest estimate ...